Based on the role of NLRP3 in obesity-related metabolic syndrome, experiments have shown that saturated fatty acids activate the NLRP3 inflammasome by inducing the destruction of NKA caused by the accumulation of saturated phosphatidylcholine and the loss of plasma membrane fluidity. Here, NLRP3 is linked to metabolic syndrome.